Lindsay Rosenwald
Chief Executive Officer bei FORTRESS BIOTECH, INC.
Vermögen: 7 Mio $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Lindsay Rosenwald
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
15
| Private Company | Investment Managers | 15 |
| Unknown | 14 | ||
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Private Company | Financial Conglomerates | 9 | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY.
5
| Subsidiary | Biotechnology | 5 |
D.H. Blair & Co., Inc.
4
| Private Company | 4 | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The private company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Cellvation, Inc.
2
| Subsidiary | 2 | |
Temple University School of Medicine
1
| College/University | Other Consumer Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lindsay Rosenwald
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member Chairman | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Chairman | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| CIPLA LIMITED | Pharmaceuticals: Other | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Chairman Chief Executive Officer Director of Finance/CFO Founder | |
| Boston University | College/University | Undergraduate Degree Undergraduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | President General Counsel Corporate Officer/Principal Private Equity Investor | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Founder Analyst-Equity Director of Finance/CFO | |
| Baruch College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| KITE PHARMA INC | Biotechnology | Founder Chief Executive Officer Corporate Officer/Principal | |
| NUVECTIS PHARMA, INC. | Chief Executive Officer Director/Board Member Director/Board Member | ||
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chairman | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Corporate Officer/Principal | ||
| TFF PHARMACEUTICALS, INC. | Director/Board Member Chief Executive Officer | ||
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree Doctorate Degree | |
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
| UROGEN PHARMA LTD. | Biotechnology | Chief Executive Officer Chairman | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
| Fordham University School of Law | College/University | Graduate Degree Graduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Graduate Degree | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| University of Florida | College/University | Graduate Degree Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree Doctorate Degree | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree Doctorate Degree | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder |
Statistik
International
| Vereinigte Staaten | 44 |
| Israel | 4 |
| Italien | 2 |
| Indien | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 15 |
| Finance | 9 |
| Commercial Services | 5 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 365 |
| Corporate Officer/Principal | 195 |
| Independent Dir/Board Member | 106 |
| Undergraduate Degree | 80 |
| Chief Executive Officer | 79 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arie Belldegrun | 42 |
| Eric Rowinsky | 36 |
| Paul Brooke | 32 |
| Bobby Sandage | 29 |
| Malcolm Hoenlein | 28 |
| J. Lobell | 27 |
| Michael Weiss | 25 |
| David Tanen | 25 |
| Ronald Renaud | 24 |
| Neil Herskowitz | 22 |
| Morris Laster | 21 |
| Eric Rose | 21 |
| Stephen Rocamboli | 20 |
| Russell Ellison | 20 |
| Harlan Weisman | 20 |
- Börse
- Insiders
- Lindsay Rosenwald
- Unternehmensverbindungen
